美国 · SEC FORM 4
Predictive Oncology Inc.
POAI · Nasdaq · CIK 0001446159 · Financial Services
内部人信号
1 qualifying P purchase group
当前 180 天评分窗口
17 同一窗口内观察到的 Form 4 交易行
0 sales · 15 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 1 additional owner(s) remain in Form 4 申报证据.
买方广度与集中度
Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-09-08 · Zhu Theodore.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
FINRA 报告中没有该股票代码的空头余额。
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | Zhu Theodore | 买入 (P) | Common Stock | 8,750 | USD 11.24 | USD 98,350 | SEC 申报 ↗ |
| 2022-12-15 | HANDLEY DANIEL E | 买入 (P) | Common Stock | 6,000 | USD 0.41 | USD 2,460 | SEC 申报 ↗ |
| 2022-12-02 | Vennare Raymond F | 买入 (P) | Common Stock | 5,000 | USD 0.52 | USD 2,600 | SEC 申报 ↗ |
| 2022-12-02 | MYERS ROBERT L | 买入 (P) | Common Stock | 8,795 | USD 0.57 | USD 5,013 | SEC 申报 ↗ |
| 2022-11-29 | HANDLEY DANIEL E | 买入 (P) | Common Stock | 10,000 | USD 0.36 | USD 3,600 | SEC 申报 ↗ |
| 2022-05-26 | HANDLEY DANIEL E | 买入 (P) | Common Stock | 2,550 | USD 0.37 | USD 944 | SEC 申报 ↗ |
| 2022-05-25 | HANDLEY DANIEL E | 买入 (P) | Common Stock | 2,800 | USD 0.35 | USD 980 | SEC 申报 ↗ |
| 2022-05-24 | ENGLE J MELVILLE | 买入 (P) | Common Stock | 159,500 | USD 0.37 | USD 59,015 | SEC 申报 ↗ |
| 2022-05-20 | Nuzum Charles Lee Sr | 买入 (P) | Common Stock | 200,000 | USD 0.31 | USD 62,000 | SEC 申报 ↗ |
| 2022-05-20 | MYERS ROBERT L | 买入 (P) | Common Stock | 16,125 | USD 0.30 | USD 4,838 | SEC 申报 ↗ |
| 2020-09-01 | GABRIEL RICHARD L | 买入 (P) | Common Stock | 4,000 | USD 0.90 | USD 3,600 | SEC 申报 ↗ |
| 2020-08-19 | GABRIEL RICHARD L | 买入 (P) | Common Stock | 3,000 | USD 1.18 | USD 3,540 | SEC 申报 ↗ |
Form 4 申报证据
26 transaction lines in the latest 365-day window; 148 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Zhu Theodore | 奖励/授予 (A) | Common Stock | 733 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-01 | ST. CLAIR GREGORY SR | 奖励/授予 (A) | Common Stock | 733 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-01 | Nuzum Charles Lee Sr | 奖励/授予 (A) | Common Stock | 733 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (25 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Zhu Theodore | 奖励/授予 (A) | Common Stock | 733 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-01 | ST. CLAIR GREGORY SR | 奖励/授予 (A) | Common Stock | 733 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-01 | Nuzum Charles Lee Sr | 奖励/授予 (A) | Common Stock | 733 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-01 | Hawryluk Matthew | 奖励/授予 (A) | Common Stock | 733 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-01 | HANDLEY DANIEL E | 奖励/授予 (A) | Common Stock | 528 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-01 | Dirks Thorsten | 奖励/授予 (A) | Common Stock | 733 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-08 | Zhu Theodore | 买入 (P) | Common Stock | 8,750 | USD 11.24 | USD 98,350 | SEC 申报 ↗ |
| 2026-07-01 | Dirks Thorsten | 奖励/授予 (A) | Common Stock | 2,420 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | Zhu Theodore | 奖励/授予 (A) | Common Stock | 2,420 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | ST. CLAIR GREGORY SR | 奖励/授予 (A) | Common Stock | 2,420 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | Nuzum Charles Lee Sr | 奖励/授予 (A) | Common Stock | 2,420 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | Hawryluk Matthew | 奖励/授予 (A) | Common Stock | 1,716 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | HANDLEY DANIEL E | 奖励/授予 (A) | Common Stock | 1,716 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-29 | Zhu Theodore | 奖励/授予 (A) | Common Stock | 11,250 | USD 6.61 | USD 74,362 | SEC 申报 ↗ |
| 2026-05-28 | Zhu Theodore | 奖励/授予 (A) | Common Stock | 3,750 | USD 6.61 | USD 24,788 | SEC 申报 ↗ |
| 2026-05-14 | Blacher Joshua | 奖励/授予 (A) | Common Stock | 9,389 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-20 | Dirks Thorsten | 奖励/授予 (A) | Common Stock | 5,144 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-20 | Zhu Theodore | 奖励/授予 (A) | Common Stock | 5,144 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-20 | Nuzum Charles Lee Sr | 奖励/授予 (A) | Common Stock | 14,082 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-20 | ST. CLAIR GREGORY SR | 奖励/授予 (A) | Common Stock | 9,419 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-20 | Hawryluk Matthew | 奖励/授予 (A) | Common Stock | 6,782 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-20 | HANDLEY DANIEL E | 奖励/授予 (A) | Common Stock | 5,663 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-05 | Vennare Raymond F | 代扣税 (F) | Common Stock | 6,758 | USD 2.59 | USD 17,503 | SEC 申报 ↗ |
| 2025-12-10 | Vennare Raymond F | 奖励/授予 (A) | Common Stock | 20,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-28 | Vennare Raymond F | 代扣税 (F) | Common Stock | 2,373 | USD 5.90 | USD 14,001 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | POAI |
| CIK | 0001446159 |
| 行业 | Financial Services |
| 细分行业 | — Yahoo Finance |
| SEC SIC | 6199 Finance Services |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 148 transaction lines from 2020-01-31 to 2026-10-01 15 P purchase lines · 2 S sale lines · 131 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.